These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22961650)

  • 1. Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro.
    Takata T; Ishigaki Y; Shimasaki T; Tsuchida H; Motoo Y; Hayashi A; Tomosugi N
    Oncol Rep; 2012 Dec; 28(6):1968-76. PubMed ID: 22961650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative proteomic profiling of pancreatic ductal adenocarcinoma cell lines.
    Kim Y; Han D; Min H; Jin J; Yi EC; Kim Y
    Mol Cells; 2014 Dec; 37(12):888-98. PubMed ID: 25518923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic gemcitabine resistance in a novel pancreatic cancer cell line is associated with cancer stem cell-like phenotype.
    Hu G; Li F; Ouyang K; Xie F; Tang X; Wang K; Han S; Jiang Z; Zhu M; Wen D; Qin X; Zhang L
    Int J Oncol; 2012 Mar; 40(3):798-806. PubMed ID: 22076649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
    Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
    Kuramitsu Y; Taba K; Ryozawa S; Yoshida K; Zhang X; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2010 Sep; 30(9):3367-72. PubMed ID: 20944110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma.
    Shekouh AR; Thompson CC; Prime W; Campbell F; Hamlett J; Herrington CS; Lemoine NR; Crnogorac-Jurcevic T; Buechler MW; Friess H; Neoptolemos JP; Pennington SR; Costello E
    Proteomics; 2003 Oct; 3(10):1988-2001. PubMed ID: 14625861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma.
    Hii LW; Lim SE; Leong CO; Chin SY; Tan NP; Lai KS; Mai CW
    BMC Complement Altern Med; 2019 Sep; 19(1):257. PubMed ID: 31521140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
    Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y
    Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs.
    Hashimoto D; Bläuer M; Hirota M; Ikonen NH; Sand J; Laukkarinen J
    Eur J Cancer; 2014 May; 50(7):1382-90. PubMed ID: 24503026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway.
    Yang H; Fan S; An Y; Wang X; Pan Y; Xiaokaiti Y; Duan J; Li X; Tie L; Ye M; Li X
    Oncotarget; 2016 Dec; 7(50):83641-83656. PubMed ID: 27845899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer.
    Horiuchi T; Uwagawa T; Shirai Y; Saito N; Iwase R; Haruki K; Shiba H; Ohashi T; Yanaga K
    J Surg Res; 2016 Nov; 206(1):1-8. PubMed ID: 27916347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
    Momeny M; Alishahi Z; Eyvani H; Esmaeili F; Zaghal A; Ghaffari P; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Cell Oncol (Dordr); 2020 Feb; 43(1):81-93. PubMed ID: 31512195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of ABCG2 expression by Wnt5a through FZD7 in human pancreatic cancer cells.
    Zhang Z; Gao S; Xu Y; Zhao C
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
    Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
    BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival prediction for pancreatic cancer patients receiving gemcitabine treatment.
    Matsubara J; Ono M; Honda K; Negishi A; Ueno H; Okusaka T; Furuse J; Furuta K; Sugiyama E; Saito Y; Kaniwa N; Sawada J; Shoji A; Sakuma T; Chiba T; Saijo N; Hirohashi S; Yamada T
    Mol Cell Proteomics; 2010 Apr; 9(4):695-704. PubMed ID: 20061307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial Flow Recapitulates Gemcitabine Chemoresistance in A 3D Microfluidic Pancreatic Ductal Adenocarcinoma Model by Induction of Multidrug Resistance Proteins.
    Kramer B; Haan L; Vermeer M; Olivier T; Hankemeier T; Vulto P; Joore J; Lanz HL
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway.
    Wang X; Wu X; Zhang Z; Ma C; Wu T; Tang S; Zeng Z; Huang S; Gong C; Yuan C; Zhang L; Feng Y; Huang B; Liu W; Zhang B; Shen Y; Luo W; Wang X; Liu B; Lei Y; Ye Z; Zhao L; Cao D; Yang L; Chen X; Haydon RC; Luu HH; Peng B; Liu X; He TC
    Sci Rep; 2018 Dec; 8(1):17914. PubMed ID: 30559409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of all-trans retinoic acid and its synergism with gemcitabine are associated with downregulation of p21-activated kinases in pancreatic cancer.
    Wang K; Baldwin GS; Nikfarjam M; He H
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G632-G640. PubMed ID: 30844294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of CD36 on Chemoresistance in Pancreatic Ductal Adenocarcinoma.
    Kubo M; Gotoh K; Eguchi H; Kobayashi S; Iwagami Y; Tomimaru Y; Akita H; Asaoka T; Noda T; Takeda Y; Tanemura M; Mori M; Doki Y
    Ann Surg Oncol; 2020 Feb; 27(2):610-619. PubMed ID: 31605325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion.
    Sumiyoshi H; Matsushita A; Nakamura Y; Matsuda Y; Ishiwata T; Naito Z; Uchida E
    Oncol Rep; 2016 Jun; 35(6):3216-26. PubMed ID: 27035235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.